Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
The Memorandum of Understanding includes the formation of a Joint Venture in the Kingdom of Saudi Arabia for manufacturing and distribution of the Company’s upcoming Co-Dx™ PCR platform and other Co-Dx IP
Definitive agreement to accelerate adoption of Renalytix’s FDA-approved, Medicare reimbursed kidneyintelX.dkd test to slow kidney disease progression and improve patient outcomes
KUDA THERAPEUTICS AWARDED $5.6M U.S. DoD GRANT TO BRING LEAD ONCOLOGY CANDIDATE INTO CLINIC
ARUP Achieves Reaccreditation Under College of American Pathologists ISO 15189 Program
Study will begin enrollment in Q1 2026 in the US and UK and leverage the BIOFIRE® SPOTFIRE® point-of-care diagnostics platform at U.S. sites.
Owlet’s new release creates the ultimate baby monitoring system for video, sleep, and medical-grade health tracking.
BioUtah Member Appreciation BBQ 2025 Recap
Kimbell & Associates: Trump Administration Issues MAHA Strategy Report of Recommendations to President Trump
If approved, ZORYVE cream would be the first and only topical PDE4 inhibitor indicated for plaque psoriasis in children as young as 2.
Salt Lake City Angels Invests in Freyya
The wearable baby monitor trusted by millions globally expands reach to three continents, including North America, Europe, and now Africa.